Mar 31, 2025 / 08:30PM GMT
Operator
Good afternoon, ladies and gentlemen, and welcome to the CytoSorbent Corp. fourth quarter and full year 2024 financial results and recent business highlights conference call. (Operator Instructions) This call is being recorded on Monday, March 31, 2025.
I would not like to turn the conference over to Adanna Alexander. Please go ahead.
Adanna Alexander - ICR Healthcare - Investor Relations
Thank you, John, and good afternoon, everyone. Welcome to Fiorin's fourth quarter and full year 2024 financial results and business highlights conference call. Joining me today from the company for the prepared remarks are Dr. Philip Chan, Chief Executive Officer; and Pete Mariani, Chief Financial Officer.
Before I turn the call over to Doctor Chan, I'd like to remind listeners that during the call, management's prepared remarks may contain forward-looking statements which are subject to risks and uncertainties. Management may make additional forward-looking statements in response to your questions today. Therefore, the company claims protection under the
Q4 2024 Cytosorbents Corp Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
